HIGHLIGHTS
- who: Catherine N. Le and colleagues from the Vanderbilt University School of Medicine, Department of Medicine, Division of Infectious Disease have published the research: Urine Eicosanoids in the Metabolic Abnormalities, Telmisartan, and HIV Infection (MATH) Trial, in the Journal: PLOS ONE | DOI:10.1371/journal.pone [0170515]. January 24, 2017 of October/25,/2016
- what: Due to the pilot nature of this study, all analyses were exploratory and no adjustment was made for multiple testing.
- future: These pilot data suggest the utility of urine eicosanoids as potential biological mediators and/or biomarkers for . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.